DIAGNOSIS OF PSEUDOPROGRESSION FOLLOWING RADIOTHERAPY PLUS LOMUSTINE-TEMOZOLOMIDE CHEMOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS USING FET PET

被引：0

作者：

Werner, Jan-Michael ^{[1
,2
]}

Ceccon, Garry ^{[1
,2
]}

Weller, Johannes ^{[3
]}

Schaub, Christina ^{[3
]}

Tscherpel, Caroline ^{[1
,2
]}

Lohmann, Philipp ^{[4
]}

Bauer, Elena ^{[1
,2
]}

Schaefer, Niklas ^{[3
]}

Stoffels, Gabriele ^{[4
]}

Kabbasch, Christoph ^{[2
,5
]}

Baues, Christian ^{[2
,6
]}

Marnitz, Simone ^{[2
,6
]}

Fink, Gereon R. ^{[1
,2
]}

Langen, Karl-Josef ^{[4
]}

Herrlinger, Ulrich ^{[3
]}

Galldiks, Norbert ^{[1
,2
]}

机构：

[1] Univ Cologne, Fac Med, Dept Neurol, Cologne, Germany

[2] Univ Cologne, Univ Hosp Cologne, Cologne, Germany

[3] Univ Hosp Bonn, Dept Neurol, Div Clin Neurooncol, Bonn, Germany

[4] Res Ctr Juelich, Inst Neurosci & Med, Julich, Germany

[5] Univ Cologne, Fac Med, Dept Neuroradiol, Cologne, Germany

[6] Univ Cologne, Fac Med, Dept Radiat Oncol, Cologne, Germany

来源：

NEURO-ONCOLOGY | 2020年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

NIMG-26

引用

页码：152 / 153

页数：3

共 50 条

[31] OUTCOMES AND PREDICTORS OF SURVIVAL FOLLOWING CONCOMITANT AND ADJUVANT TEMOZOLOMIDE WITH RADIOTHERAPY FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
Swaminath, A.
McMillan, W.
McCarter, H.
Hirte, H.
Whitton, A.
RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S52 - S52
[32] PHASE I TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY WITH TEMOZOLOMIDE CHEMOTHERAPY FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
Chen, Changhu
Damek, Denise
Gaspar, Laurie E.
Waziri, Allen
Lillehei, Kevin
Kleinschmidt-DeMasters, B. K.
Robischon, Monica
Stuhr, Kelly
Rusthoven, Kyle E.
Kavanagh, Brian D.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (04): : 1066 - 1074
[33] Temozolomide with or without Radiotherapy in Patients with Newly Diagnosed Glioblastoma Multiforme: A Meta-Analysis
Feng, Enshan
Sui, Changbai
Wang, Tongxin
Sun, Gaoling
EUROPEAN NEUROLOGY, 2017, 77 (3-4) : 201 - 210
[34] TUMOR TREATING FIELDS (TTFIELDS) IN COMBINATION WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
Lazaridis, L.
Schaefer, N.
Kebir, S.
Weller, J.
Tzaridis, T.
Schaeffler, B.
Pierscianek, D.
Kleinschnitz, C.
Stuschke, M.
Sure, U.
Herrlinger, U.
Glas, M.
NEURO-ONCOLOGY, 2018, 20 : 230 - 230
[35] SPATIAL DISCREPANCIES BETWEEN FET PET AND CONVENTIONAL MRI IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Lohmann, P.
Stavrinou, P.
Lipke, K.
Bauer, E. K.
Ceccon, G.
Werner, J.
Fink, G. R.
Shah, N. J.
Langen, K.
Galldiks, N.
NEURO-ONCOLOGY, 2019, 21 : 74 - 74
[36] AVASTIN AND TEMOZOLOMIDE FOLLOWING RADIATION AND CHEMOTHERAPY FOR NEWLY DIAGNOSED GLIOBLASTOMA: RESULTS OF A PHASE II STUDY
Nicholas, M. K.
Chmura, S.
Paleologos, Nina
Krouwer, Hendrikus
Malkin, Mark
Junck, Larry
Vick, Nicholas A.
Lukas, Rimas V.
NEURO-ONCOLOGY, 2011, 13 : 88 - 89
[37] Radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma (vol 352, pg 19, 2005)
Stupp, R
Mason, WP
van den Beuf, MJ
ANNALS OF ONCOLOGY, 2005, 16 (06) : 949 - 949
[38] MAINTENANCE TEMOZOLOMIDE CHEMOTHERAPY FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA: DOES TIME OF ADMINISTRATION MATTER?
Geurts, M.
Berchtold, L.
Koenig, F.
Naburs, B.
Reardon, D. A.
Tonn, J. C.
Stupp, R.
Gorlia, T.
Weller, M.
Preusser, M.
NEURO-ONCOLOGY, 2024, 26 : V9 - V9
[39] A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients
Pan, Edward
Mitchell, Susan B.
Tsai, Jerry S.
JOURNAL OF NEURO-ONCOLOGY, 2008, 88 (03) : 353 - 357
[40] A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients
Edward Pan
Susan B. Mitchell
Jerry S. Tsai
Journal of Neuro-Oncology, 2008, 88 : 353 - 357

← 1 2 3 4 5 →